Promising therapies for treatment of nonalcoholic steatohepatitis.

Volume: 21, Issue: 3, Pages: 343 - 357
Published: Aug 28, 2016
Abstract
Introduction: Non-alcoholic fatty liver disease (NAFLD) has become the most common etiology for abnormal aminotransferase levels and chronic liver disease. Its growing prevalence is largely linked to the presence of metabolic syndrome, particularly diabetes and insulin resistance. It is estimated that 60–80% of the type 2 diabetic population has NAFLD. NAFLD encompasses a range of conditions ranging from simple steatosis to non-alcoholic...
Paper Details
Title
Promising therapies for treatment of nonalcoholic steatohepatitis.
Published Date
Aug 28, 2016
Volume
21
Issue
3
Pages
343 - 357
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.